Amgen's Sharer and Amgen's share price: movement at last
This article was originally published in Scrip
Amgen has said that chairman and chief executive officer Kevin Sharer, who has been at the helm for the past decade, will retire as CEO next May and continue as chairman until the end of 2012. Robert Bradway, a former Wall Street executive who is the company’s chief operating officer, will succeed him. On news of the moves 15 December, the company’s share price was up $1, to $58.62; the shares closed at $60 on 16 December.